Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Research Article

Network Pharmacology Integrated Molecular Docking to Reveal the Autism and Mechanism of Baohewan Heshiwei Wen Dan Tang

Author(s): Yongjian Chen, Kang Ma, Hongzong Si*, Yunbo Duan and Honglin Zhai

Volume 28, Issue 39, 2022

Published on: 02 November, 2022

Page: [3231 - 3241] Pages: 11

DOI: 10.2174/1381612828666220926095922

Price: $65

Abstract

Background: In recent years, the prevalence and mortality of autism spectrum disorder (ASD) have been increasing. The clinical features are different with different cases, so the treatment ways are different for each one.

Objective: Baohewan Heshiwei Wen Dan Tang (BHWDT) has been recommended for treating autistic spectrum disorder. To investigate the mechanism of action and how the compounds interact with ASD targets, network pharmacology and molecular docking methods were used in this study.

Methods: Traditional Chinese Medicine Systems Pharmacology (TCMSP) was used to screen the active components according to index of oral bio-activity and drug-likeness. Then, TCMSP and Swiss Target Prediction databases were used to screen potential target genes of active components. The related target genes of ASD were obtained from the Gene Cards database. Matescape database was utilized to get gene ontology (GO) function enrichment and Kyoto Encyclopedia of Genes and Genomes pathway annotation of gene targets. Composition- target-pathway (C-T-P) and a protein-protein interaction (PPI) networks were built with Cytoscape 3.8.2 software.

Results: The interaction of the main active components of BHWDT was verified by molecular docking. The key targets of MAPK1, IL6, CXCL8 and TP53 of BHWDT were obtained. The key active components Quercetin, Kaempferol and Iuteolin of BHWDT could bind with MAPK1, IL6, CXCL8 and TP53 of BHWDT, respectively.

Conclusion: BHWDT can be highly effective for treating ASD and this study can help us to understand multiple targets and multiple pathways mechanism.

Keywords: BHWDT, Autistic spectrum disorder, Network pharmacology, TCMSP, Dock, Protein–protein interaction

« Previous
[1]
Fombonne E. The epidemiology of autism: A review. Psychol Med 1999; 29(4): 769-86.
[http://dx.doi.org/10.1017/S0033291799008508] [PMID: 10473304]
[2]
Shunsen C, Xuejun B, Risheng Z. Symptoms, diagnosis, and intervention of autism spectrum disorder. Adv Psychol Sci 2011; 19(1): 13.
[3]
Kanner L. Follow-up study of eleven autistic children origi-nally reported in 1943. J Autism Child Schizophr 1971; 1(2): 119-45.
[http://dx.doi.org/10.1007/BF01537953] [PMID: 5172388]
[4]
Rahbar MH, Loveland KA, Samms-Vaughan M, Boerwinkle E, Ardjomand-Hessabi M. Gene-environment related epide-miological research on autism in Jamaica. International Meet-ing for Autism Research 2010. Available from: face-book.com/autismINSAR
[5]
Grace H. Research progress on autism rehabilitation. C The 3rd Beijing International Rehabilitation Forum. Available from: https://mail.google.com/mail/u/0/#search/BMS-CPD-2022-376? projector=1&messagePartId=0.1
[6]
Elsabbagh M, Divan G, Koh YJ, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012; 5(3): 160-79.
[http://dx.doi.org/10.1002/aur.239] [PMID: 22495912]
[7]
Hyla C, Jerry C. Herbal medicine. M. Handbook of Complementary and Alternative Therapies in Mental Health Academic Press Massachusetts. 2002; pp. 377-400.
[8]
Cai JL, Lu JQ, Lu G, Guo SN, Wan LJBS. Autism spectrum disorder related TCM symptoms and TCM herbs prescrip-tions: A systematic review and meta-analysis. North Am J Med Sci 2015; 8(1): 20-30.
[9]
Wake R, Miyaoka T, Furuya M, Hashioka S, Horiguchi J. Effects of yokukansan, a Japanese kampo medicine for symptoms associated autism spectrum disorder. CNS Neurol Disord Drug Targets 2016; 15(5): 551-63.
[10]
Shamsi Y, Nikhat S, Mukherjee A, Gombar V, Sinha S. Role of unani neuroprotective herbal drugs in the management of autism. Int J Med Res Rev 2019; 6(9): 12-20.
[11]
Lintin Z, Ciai L. Yanhongs et al. A multi-target and multi-channel mechanism of action for Jiawei Yinhuo Tang in the treatment of social communication disorders in autism: Net-work pharmacology and molecular docking studies. Evid Based Complement Alternat Med 2022; 4093138.
[12]
Hopkins AL. Network pharmacology. Nat Biotechnol 2007; 25(10): 1110-1.
[http://dx.doi.org/10.1038/nbt1007-1110] [PMID: 17921993]
[13]
Zhang Y, Mao X, Guo Q, Lin N, Li S. Network pharmacolo-gy-based approaches capture essence of Chinese herbal med-icines. Chin Herb Med 2016; 8(2): 107-16.
[http://dx.doi.org/10.1016/S1674-6384(16)60018-7]
[14]
Zhang XN, Zhang JP, Zhang SX. Study on potential mecha-nism of Huanglian Jiedu decoction in treating hypertension based on internet pharmacology. Chin Herb Med 2018; 49(24): 5865-75.
[15]
Kohl M, Wiese S, Warscheid B. Cytoscape: Software for visualization and analysis of biological networks. Methods Mol Biol 2011; 696: 291-303.
[http://dx.doi.org/10.1007/978-1-60761-987-1_18] [PMID: 21063955]
[16]
Cheng L, Wang F, Zhang SB, You QY. Network pharmacolo-gy integrated molecular docking reveals the anti-COVID-19 and SARS mechanism of fufang banlangen keli. Nat Prod Commun 2021; 16(1): 1934578X2098842.
[http://dx.doi.org/10.1177/1934578X20988420]
[17]
Andrea F, Damian S, Sune F. STRING v9.1: Protein-protein interaction networks, with increased coverage and integra-tion. J Nar 2012; 41(D1)
[18]
Hutsler JJ, Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res 2010; 1309: 83-94.
[http://dx.doi.org/10.1016/j.brainres.2009.09.120] [PMID: 19896929]
[19]
Huang JY, Tian Y, Wang HJ, et al. Functional genomic anal-yses identify pathways dysregulated in animal model of au-tism. CNS Neurosci Ther 2016; 22(10): 845-53.
[http://dx.doi.org/10.1111/cns.12582] [PMID: 27321591]
[20]
Lauss M, Kriegner A, Vierlinger K, Noehammer C. Charac-terization of the drugged human genome. Pharmacogenomics 2007; 8(8): 1063-73.
[http://dx.doi.org/10.2217/14622416.8.8.1063] [PMID: 17716238]
[21]
Rubinfeld H, Seger R. The ERK cascade: A prototype of MAPK signaling. Mol Biotechnol 2005; 31(2): 151-74.
[http://dx.doi.org/10.1385/MB:31:2:151] [PMID: 16170216]
[22]
Murphy LO, Blenis J. MAPK signal specificity: The right place at the right time. Trends Biochem Sci 2006; 31(5): 268-75.
[http://dx.doi.org/10.1016/j.tibs.2006.03.009] [PMID: 16603362]
[23]
Horwood JM, Dufour F, Laroche S, Davis S. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci 2006; 23(12): 3375-84.
[http://dx.doi.org/10.1111/j.1460-9568.2006.04859.x] [PMID: 16820027]
[24]
Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guas-tella AJ. Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis. Mol Psychiatry 2015; 20(4): 440-6.
[http://dx.doi.org/10.1038/mp.2014.59] [PMID: 24934179]
[25]
Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 2014; 6(10): a016295.
[http://dx.doi.org/10.1101/cshperspect.a016295] [PMID: 25190079]
[26]
Boulangerm LM. Immune proteins in brain development and synaptic plasticity. J Neuron 2009; 93-109.
[27]
Li B, Jones LL, Geiger TL. IL-6 promotes T cell proliferation and expansion under inflammatory conditions in association with low-level RORγt expression. J Immunol 2018; 201(10): 2934-46.
[http://dx.doi.org/10.4049/jimmunol.1800016] [PMID: 30315140]
[28]
Oh J, McCloskey MA, Blong CC, Bendickson L, Nilsen-Hamilton M, Sakaguchi DS. Astrocyte-derived interleukin-6 promotes specific neuronal differentiation of neural progeni-tor cells from adult hippocampus. J Neurosci Res 2010; 88(13): 2798-809.
[http://dx.doi.org/10.1002/jnr.22447] [PMID: 20568291]
[29]
Rudolph MD, Graham AM, Feczko E, et al. Maternal IL-6 during pregnancy can be estimated from newborn brain con-nectivity and predicts future working memory in offspring. Nat Neurosci 2018; 21(5): 765-72.
[http://dx.doi.org/10.1038/s41593-018-0128-y] [PMID: 29632361]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy